NIAID Preclinical Development Support - Production of a HIV gp145 Clade C Trimer Protein
- Institution
- ADVANCED BIOSCIENCE LABORATORIES, INC., MD
- Principal investigator
- Timothy Fouts
- Funding
- $25K
- Duration
- 2025
Moonbase score
Still being scored
Abstract
This contract will provide NIAID with a broad and flexible range of nontraditional, proactive and developmentally-oriented capabilities to provide preclinical development support for promising products when such products emerge from investigator-initiated research studies. These capabilities will allow NIAID to more rapidly and efficiently close development and production gaps. Activities include but are not limited to small-scale production, preclinical testing and documentation leading to Investigational New Drug (IND) submission for Phase I, II, and III clinical testing.
LOADING MOONBASE SCORE
Questions for ADVANCED BIOSCIENCE LABORATORIES, INC.
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Advanced Bioscience Laboratories, Inc.Not yet scored
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
Timothy Fouts · $181K · 2025–2028
- NIH · Advanced Bioscience Laboratories, Inc.Not yet scored
Production of a Chimpanzee Adenovirus HIV-1 Vaccine
Timothy Fouts · $84K · 2016–2028
- NIH · Advanced Bioscience Laboratories, Inc.Not yet scored
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of Clade B, B.63521Δ11 gp120 Env Protein
Timothy Fouts · $47K · 2014–2025